Cargando…

The employment of vaccinia virus for colorectal cancer treatment: A review of preclinical and clinical studies

Colorectal cancer (CRC) is one of the leading malignancies that causes death worldwide. Cancer vaccines and oncolytic immunotherapy bring new hope for patients with advanced CRC. The capability of vaccinia virus (VV) in carrying foreign genes as antigens or immunostimulatory factors has been demonst...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ling, Qiaoyun, Zheng, Bichun, Chen, Xudong, Ye, Shaoshun, Cheng, Quan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2022
Materias:	Immunotherapeutics – Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9746450/ https://www.ncbi.nlm.nih.gov/pubmed/36369829 http://dx.doi.org/10.1080/21645515.2022.2143698

Ejemplares similares

Role and therapeutic potential of DEAD-box RNA helicase family in colorectal cancer
por: Zheng, Bichun, et al.
Publicado: (2023)

Review of bimekizumab in the treatment of psoriasis
por: Koppu, Sindhuja, et al.
Publicado: (2022)

The progress of peptide vaccine clinical trials in gynecologic oncology
por: Tang, Mi, et al.
Publicado: (2022)

Immune checkpoint inhibitors in esophageal cancer: Clinical development and perspectives
por: Nagata, Yusuke, et al.
Publicado: (2022)

Current updates on generations, approvals, and clinical trials of CAR T-cell therapy
por: Asmamaw Dejenie, Tadesse, et al.
Publicado: (2022)

Therapeutic potential of mesenchymal stem cells for refractory inflammatory and immune skin diseases
por: Hua, Chunting, et al.
Publicado: (2022)

Vaccines as a preventive tool for substance use disorder: A systematic review including a meta-analysis on nicotine vaccines’ immunogenicity
por: Scendoni, Roberto, et al.
Publicado: (2022)

Immunotherapy of glioblastoma: Recent advances and future prospects
por: Yuan, Boyang, et al.
Publicado: (2022)

Adoptive tumor infiltrating lymphocytes cell therapy for cervical cancer
por: Zhu, Yahui, et al.
Publicado: (2022)

PD-1 inhibitor treatment in a penile cancer patient with MMR/MSI status heterogeneity: A case report
por: Du, YunYi, et al.
Publicado: (2022)

Waning of maternal antibody against measles virus in Shufu, China
por: He, Qing, et al.
Publicado: (2022)

Anti CD38 monoclonal antibodies for multiple myeloma treatment
por: Gozzetti, Alessandro, et al.
Publicado: (2022)

Update about Oralair® as a treatment for grass pollen allergic rhinitis
por: Klimek, L., et al.
Publicado: (2022)

Advancing humanized monoclonal antibody for counteracting fentanyl toxicity towards clinical development
por: Hicks, Dustin, et al.
Publicado: (2022)

Long-term survival after immunotherapy and targeted therapy without chemotherapy in an elderly patient with HER2-positive gastroesophageal junction cancer: A case report
por: Li, Wei-Ling, et al.
Publicado: (2022)

Introduction
por: Zhao, Peter, et al.
Publicado: (2011)

Radioimmunotherapy of Non-Hodgkin’s Lymphoma: From the ‘Magic Bullets’ to ‘Radioactive Magic Bullets’
por: Chamarthy, Murthy R., et al.
Publicado: (2011)

Ipilimumab and Cancer Immunotherapy: A New Hope for Advanced Stage Melanoma
por: Mansh, Matthew
Publicado: (2011)

Regulating Caspase-1 During Infection: Roles of NLRs, AIM2, and ASC
por: Case, Christopher L.
Publicado: (2011)

Cancer Immunotherapy Takes a Multi-Faceted Approach to Kick the Immune System into Gear
por: Dimberu, Peniel M., et al.
Publicado: (2011)

Learning to Live Together: Harnessing Regulatory T cells to Induce Organ Transplant Tolerance
por: Chang, Andrew Y., et al.
Publicado: (2011)

Blockade of the B7-H1/PD-1 Pathway for Cancer Immunotherapy
por: Flies, Dallas B., et al.
Publicado: (2011)

Nanoparticle Delivery of Anti-Tuberculosis Chemotherapy as a Potential Mediator Against Drug-Resistant Tuberculosis
por: Smith, Jonathan Paul
Publicado: (2011)

Vaccination: The Present and the Future
por: Sadanand, Saheli
Publicado: (2011)

Development and evaluation of a tetravalent botulinum vaccine
por: Shi, Dan-Yang, et al.
Publicado: (2022)

Human placental hematopoietic stem cell derived natural killer cells (CYNK-001) mediate protection against influenza a viral infection
por: Gleason, Joseph, et al.
Publicado: (2022)

Belimumab for systemic lupus erythematosus – Focus on lupus nephritis
por: Plüß, Marlene, et al.
Publicado: (2022)

MicroRNA-873-5p suppresses cell malignant behaviors of thyroid cancer via targeting CXCL5 and regulating P53 pathway
por: Chang, Wang, et al.
Publicado: (2022)

Relationship between T-cell-dependent and T-cell-independent vaccines after neurotrauma; is the B-cell response preserved?
por: Ljunghill Hedberg, Anna, et al.
Publicado: (2022)

Efficacy and safety of immune checkpoint inhibitors in advanced pancreatic cancer: A real world study in Chinese cohort
por: Gong, Xiaoling, et al.
Publicado: (2022)

CIMT 2022: Report on the 19th Annual Meeting of the Association for Cancer Immunotherapy
por: Berger, Peer Andre, et al.
Publicado: (2022)

RSV-related hospitalization and outpatient palivizumab use in very preterm (born at <29 wGA) infants: 2003-2020
por: Packnett, Elizabeth R., et al.
Publicado: (2022)

Nanovaccines: Merits, and diverse roles in boosting antitumor immune responses
por: Yin, Qiliang, et al.
Publicado: (2022)

Near complete response to a pembrolizumab-based therapeutic strategy in an abdominal metastatic head and neck squamous cell carcinoma case
por: Wu, Taowei, et al.
Publicado: (2022)

Omalizumab added to allergen immunotherapy increased the effect of therapy in patients with severe local allergic rhinitis
por: Bozek, Andrzej, et al.
Publicado: (2022)

Expert consensus on the role of OM-85 in the management of recurrent respiratory infections: A Delphi study
por: Esposito, Susanna, et al.
Publicado: (2022)

Intravenous injection of a novel viral immunotherapy encoding human interleukin-7 in nonhuman primates is safe and increases absolute lymphocyte count
por: Coupet, Charles-Antoine, et al.
Publicado: (2022)

Vaccination with a shared oncogenic tumor-self antigen elicits a population of CD8+ T cells with a regulatory phenotype
por: Elizondo, C. Riccay, et al.
Publicado: (2022)

Monitoring of molecular profiling of allergen-antibody responses in HDM-immunotherapy patients
por: Nittner-Marszalska, Marita, et al.
Publicado: (2022)

Safety and efficacy of immune checkpoint inhibitors in advanced cancer patients with autoimmune disease: A meta-analysis
por: Cai, Qi, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_7cipcsgrpf2dueu2n1rjdmhcec